Homeovitality Fibrocare has been designed to target the genes, KEAP1, DEFB1 and PPARG. KEAP1 suppresses tumour growth. PPARG has been shown to kill fibroids cells and DEFB1 provides protection against infection.
May be taken safely on a long term basis.
What do the genes KEAP1, PPARG and DEFB1 do?
KEAP1 is a recently discovered master tumour suppressor gene. Scientists at the M. D. Anderson's Department of Molecular and Cellular Oncology discovered how it works [1]. It suppresses tumour growth by destruction of oncoproteins, proteins that promote tumour growth. It also inhibits tumour invasion or spreading and helps to cut off a tumour’s blood supply so that it its growth is arrested.
Dr. Nam and colleagues [2] have demonstrated that up-regulation of PPARG is helpful in treatment of (leiomyomas) fibroids. They have discovered that stabilisation of the activity of PPARG slows down the growth of fibroids. It also triggers a self-destruct mechanism which causes fibroid cells to kill themselves.
When fibroid cells are killed by the action of PPARG for example, the uterus and uro-genital tract become more prone to infection. The DEFB1 gene produces a small natural anti-bacterial peptide [3] that protects all tissue surfaces from infection. DEFB1 is targeted to help reduce the risk of intra-uterine infection when fibroid cell numbers are diminished.
References
- University of Texas M. D. Anderson Cancer Center (2009, October 10). New Tumor Suppressor Destroys Key Link In Cancer Chain. ScienceDaily. Retrieved April 13, 2012..
- Nam D H et al., Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone. Mol. Hum. Reprod.. 2007: 13; 829.
- Valore E V et al., Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 1998:101; 1633.